Vitamins and Coenzymes — MCQs

A 30-year-old chronically malnourished male presented with complaints of weakness, lassitude, anorexia, abdominal discomfort, diarrhea, apathy, lethargy, and mild disorientation. On examination, glossitis and dermatitis in sun-exposed areas were noted. All of the following enzymes use the above deficient vitamin as a coenzyme EXCEPT:

Q168Easy

Folinic acid is:

Q169Easy

Thiamine level is best monitored by?

Q170Easy

Folate trap occurs due to the deficiency of which vitamin?

Vitamins and Coenzymes Indian Medical PG Practice Questions and MCQs

Question 161: Which of the following is NOT seen in hypervitaminosis A?

A. Alopecia
B. Polyuria (Correct Answer)
C. Pseudotumor cerebri
D. Hyperlipidemia

Explanation: **Explanation:** Hypervitaminosis A (Vitamin A toxicity) occurs due to the excessive intake of preformed Vitamin A (retinoids), leading to multi-systemic manifestations. **Why Polyuria is the Correct Answer:** **Polyuria** is not a feature of Vitamin A toxicity. Instead, polyuria and polydipsia are classic hallmarks of **Hypervitaminosis D**, where excessive calcium mobilization leads to hypercalcemia and a subsequent decrease in the kidney's concentrating ability (nephrogenic diabetes insipidus). **Analysis of Incorrect Options:** * **Alopecia:** Chronic Vitamin A toxicity leads to skin and mucosal changes, including dry, itchy skin, desquamation, and significant hair loss (alopecia). * **Pseudotumor Cerebri:** This is a high-yield association. Excess Vitamin A interferes with the resorption of cerebrospinal fluid (CSF), leading to increased intracranial pressure. Clinical signs include headache, papilledema, and cranial nerve palsies. * **Hyperlipidemia:** Retinoids stimulate the synthesis of triglycerides and VLDL in the liver, often leading to significant hypertriglyceridemia and hypercholesterolemia in toxic states. **NEET-PG High-Yield Pearls:** 1. **Teratogenicity:** Vitamin A is highly teratogenic (Category X); it can cause craniofacial abnormalities and cardiac defects in the fetus. Pregnancy must be ruled out before starting isotretinoin. 2. **Acute Toxicity:** Can present as "Polar Bear Liver" poisoning, characterized by sudden vomiting, headache, and vertigo. 3. **Bone Changes:** Chronic toxicity causes cortical thickening and painful hyperostosis. 4. **Storage:** Vitamin A is stored in the **Ito cells** (stellate cells) of the liver.

Question 162: How many mg of Tryptophan are required to produce 1 mg of Niacin?

A. 22
B. 37
C. 55
D. 60 (Correct Answer)

Explanation: **Explanation:** The correct answer is **60 mg**. This is a classic high-yield fact in biochemistry regarding the endogenous synthesis of Niacin (Vitamin B3). **1. Why 60 mg is correct:** In the human body, Niacin can be synthesized from the essential amino acid **Tryptophan** via the **Kynurenine pathway**. This process is relatively inefficient; it takes approximately **60 mg of dietary Tryptophan to produce 1 mg of Niacin**. This relationship is expressed as **1 Niacin Equivalent (NE) = 1 mg Niacin or 60 mg Tryptophan.** This pathway is crucial because it explains why populations consuming diets high in Tryptophan (like milk and eggs) do not develop Niacin deficiency, even if their direct Niacin intake is low. **2. Why other options are incorrect:** * **Options A (22), B (37), and C (55):** These values do not represent any established physiological conversion ratio for Niacin synthesis. They are distractors often used in exams to confuse students who may remember that a "large" number is required but cannot recall the specific 60:1 ratio. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Cofactors:** The conversion of Tryptophan to Niacin requires **Vitamin B6 (Pyridoxine)**, **Vitamin B2 (Riboflavin)**, and **Iron**. A deficiency in B6 can lead to secondary Niacin deficiency (Pellagra). * **Pellagra:** Characterized by the **4 Ds**: Dermatitis (Casal’s necklace), Diarrhea, Dementia, and Death. * **Hartnup Disease:** A genetic defect in the transport of neutral amino acids (including Tryptophan) in the gut and kidneys, leading to Pellagra-like symptoms due to decreased Tryptophan availability. * **Carcinoid Syndrome:** Can cause Niacin deficiency because Tryptophan is diverted away from Niacin synthesis to overproduce **Serotonin (5-HT)**.

Question 163: Which of the following acts as a cofactor after its modification?

A. Vitamin C
B. Pantothenic acid (Correct Answer)
C. Biotin
D. Zinc

Explanation: **Explanation** The correct answer is **Pantothenic acid (Vitamin B5)**. **Why Pantothenic Acid is Correct:** Most water-soluble vitamins act as precursors to coenzymes. Pantothenic acid itself is biologically inactive; it must undergo significant structural modification to become **Coenzyme A (CoA)** or **Acyl Carrier Protein (ACP)**. The synthesis involves phosphorylation and the addition of cysteine and ATP. These modified forms are essential for the metabolism of carbohydrates, lipids, and proteins, specifically in the transfer of acyl groups (e.g., Acetyl-CoA in the TCA cycle). **Analysis of Incorrect Options:** * **Vitamin C (Ascorbic Acid):** Unlike B-complex vitamins, Vitamin C acts as a cofactor in its **native state** (as a reducing agent). It does not require complex enzymatic conversion into a different molecule to function in hydroxylation reactions (e.g., collagen synthesis). * **Biotin (Vitamin B7):** While Biotin must be covalently linked to carboxylase enzymes (via a lysine residue to form Biocytin), it does not undergo a structural chemical modification of its core ring system to become active. It acts as a prosthetic group in its original form. * **Zinc:** This is a **trace element/mineral**, not a vitamin. It acts as a metallic cofactor (metalloprotein) directly in its ionic form ($Zn^{2+}$) without any chemical modification. **High-Yield Clinical Pearls for NEET-PG:** * **Burning Feet Syndrome:** The classic clinical deficiency associated with Pantothenic acid. * **Key Enzyme:** Pantothenate kinase is the rate-limiting enzyme in the conversion of Pantothenic acid to Coenzyme A. * **Mnemonic:** Remember "Pantothenic" sounds like "Penta" (5), representing Vitamin B5 and its role in the 5-carbon containing Coenzyme A.

Question 164: Which of the following does not have a role in regulating Vitamin D metabolism?

A. Liver
B. Lungs (Correct Answer)
C. Kidney
D. Skin

Explanation: **Explanation:** Vitamin D metabolism is a multi-step process involving specific organs that facilitate its synthesis and activation. The **Lungs (Option B)** do not play a physiological role in the metabolic pathway of Vitamin D, making it the correct answer. **Why the other options are involved:** * **Skin (Option D):** This is the site of synthesis. Under the influence of UV-B light, **7-dehydrocholesterol** is converted into **Cholecalciferol (Vitamin D3)**. * **Liver (Option A):** Cholecalciferol travels to the liver, where the enzyme **25-hydroxylase** converts it into **25-hydroxycholecalciferol [25(OH)D3]** or Calcidiol. This is the major storage form and the marker used to clinically assess Vitamin D status. * **Kidney (Option C):** This is the site of final activation. The enzyme **1-alpha-hydroxylase** (stimulated by PTH) converts 25(OH)D3 into **1,25-dihydroxycholecalciferol [1,25(OH)2D3]** or **Calcitriol**, which is the biologically active form. **High-Yield Clinical Pearls for NEET-PG:** 1. **Rate-limiting step:** The renal 1-alpha-hydroxylation is the most tightly regulated step in Vitamin D activation. 2. **Storage vs. Active form:** 25-hydroxycholecalciferol (Calcidiol) has the longest half-life; 1,25-dihydroxycholecalciferol (Calcitriol) is the most potent. 3. **Sarcoidosis Connection:** While the lungs aren't part of normal metabolism, in granulomatous diseases like Sarcoidosis, alveolar macrophages can express 1-alpha-hydroxylase, leading to hypercalcemia. 4. **Enzyme Deficiency:** Deficiency of 1-alpha-hydroxylase leads to **Vitamin D Dependent Rickets Type 1**.

Question 165: An individual with megaloblastic anemia is found to have a significant folate deficiency. Erythropoiesis is hampered in this patient due to his inability to perform which type of enzymatic reaction?

A. Acyl transfer
B. Carboxylation
C. Decarboxylation
D. Methylation (Correct Answer)

Explanation: **Explanation:** The correct answer is **Methylation**. Folate (Vitamin B9) in its active form, **Tetrahydrofolate (THF)**, serves as a carrier of one-carbon units (methyl, methylene, methenyl, formyl, and formimino groups). In the context of erythropoiesis, folate is essential for the synthesis of **dTMP (deoxythymidine monophosphate)** from dUMP. This reaction, catalyzed by *thymidylate synthase*, requires the transfer of a methyl group from N5,N10-methylene THF. A deficiency in folate leads to impaired DNA synthesis, causing "nuclear-cytoplasmic asynchrony" where the nucleus matures slower than the cytoplasm, resulting in **megaloblastic anemia**. Additionally, the conversion of homocysteine to methionine requires the transfer of a methyl group from N5-methyl THF (the "methyl trap" link with Vitamin B12). **Why other options are incorrect:** * **Acyl transfer:** This is primarily the function of **Coenzyme A (Vitamin B5)** and Thiamine (B1). * **Carboxylation:** This involves the addition of $CO_2$, a process dependent on **Biotin (Vitamin B7)** (e.g., Pyruvate carboxylase). * **Decarboxylation:** This is typically mediated by **Pyridoxal Phosphate (PLP/Vitamin B6)** or **Thiamine Pyrophosphate (TPP/Vitamin B1)**. **High-Yield Clinical Pearls for NEET-PG:** * **FIGLU Excretion Test:** Histidine loading leads to increased Formiminoglutamate (FIGLU) in urine in folate deficiency. * **The Methyl Trap Hypothesis:** Vitamin B12 deficiency leads to a functional folate deficiency because folate remains trapped as N5-methyl THF, unable to be recycled. * **Drug Link:** **Methotrexate** inhibits *Dihydrofolate Reductase (DHFR)*, preventing the regeneration of THF, thus mimicking folate deficiency.

Question 166: What is the biochemical role of vitamin K in the post-translational modification of clotting factors?

A. Glycosylation
B. Carboxylation (Correct Answer)
C. Acetylation
D. Phosphorylation

Explanation: **Biochemical Explanation:** Vitamin K serves as an essential cofactor for the enzyme **gamma-glutamyl carboxylase**. This enzyme catalyzes the addition of a carboxyl group ($CO_2$) to specific **glutamic acid (Glu)** residues on the N-terminal end of clotting factors. This post-translational modification converts them into **gamma-carboxyglutamic acid (Gla)** residues. The addition of this second carboxyl group gives the proteins a strong negative charge, allowing them to bind **Calcium ($Ca^{2+}$) ions**. This calcium binding acts as a "bridge," enabling the clotting factors to anchor onto the negatively charged phospholipid membranes of activated platelets, which is a prerequisite for the coagulation cascade. **Analysis of Options:** * **A. Glycosylation:** This involves the addition of carbohydrates to proteins (e.g., in the Golgi apparatus) and is not mediated by Vitamin K. * **C. Acetylation:** This is the addition of an acetyl group (common in histone modification) and is unrelated to the activation of clotting factors. * **D. Phosphorylation:** This is the addition of a phosphate group by kinases, primarily used in signal transduction and enzyme regulation. **High-Yield Clinical Pearls for NEET-PG:** * **Vitamin K Dependent Factors:** Factors **II, VII, IX, X**, and Proteins **C and S**. * **Warfarin Mechanism:** It inhibits **Vitamin K Epoxide Reductase (VKOR)**, preventing the regeneration of active (reduced) Vitamin K, thereby inhibiting carboxylation. * **Lab Marker:** Prothrombin Time (PT) is the most sensitive marker for Vitamin K deficiency because Factor VII has the shortest half-life. * **Newborns:** They are born with sterile guts (no Vitamin K-producing bacteria) and low placental transfer, necessitating a prophylactic Vitamin K injection to prevent **Hemorrhagic Disease of the Newborn**.

Question 167: A 30-year-old chronically malnourished male presented with complaints of weakness, lassitude, anorexia, abdominal discomfort, diarrhea, apathy, lethargy, and mild disorientation. On examination, glossitis and dermatitis in sun-exposed areas were noted. All of the following enzymes use the above deficient vitamin as a coenzyme EXCEPT:

A. Glyceraldehyde 3-phosphate dehydrogenase
B. Beta-ketoacyl reductase
C. Pyruvate dehydrogenase
D. Transaminase (Correct Answer)

Explanation: ### Explanation **Clinical Diagnosis: Pellagra (Vitamin B3 / Niacin Deficiency)** The patient presents with the classic "3 Ds" of Pellagra: **Dermatitis** (Casal’s necklace/sun-exposed areas), **Diarrhea**, and **Dementia** (lethargy, apathy, disorientation), along with glossitis. This indicates a deficiency of **Niacin (Vitamin B3)**, which serves as a precursor for the coenzymes **NAD+** and **NADP+**. **Why Transaminase is the Correct Answer:** Transaminases (e.g., ALT, AST) do not use Niacin. Instead, they require **Pyridoxal Phosphate (PLP)**, the active form of **Vitamin B6**, as a mandatory coenzyme for the transfer of amino groups. **Analysis of Incorrect Options (Enzymes that DO use Niacin):** * **Glyceraldehyde 3-phosphate dehydrogenase:** A key enzyme in glycolysis that requires **NAD+** as an electron acceptor to convert G3P to 1,3-bisphosphoglycerate. * **Beta-ketoacyl reductase:** A component of the Fatty Acid Synthase complex involved in lipogenesis; it requires **NADPH** as a reducing agent. * **Pyruvate dehydrogenase (PDH):** A multi-enzyme complex that converts pyruvate to Acetyl-CoA. It requires five cofactors: Thiamine (B1), Riboflavin (B2), **Niacin (B3 as NAD+)**, Pantothenic acid (B5), and Lipoic acid. **High-Yield Clinical Pearls for NEET-PG:** * **Precursor:** Niacin can be synthesized from the amino acid **Tryptophan** (60 mg Tryptophan = 1 mg Niacin). * **Hartnup Disease:** Defective transport of neutral amino acids (Tryptophan) leading to pellagra-like symptoms. * **Carcinoid Syndrome:** Increased tryptophan metabolism into serotonin leads to secondary niacin deficiency. * **Corn/Maize Diets:** Low in tryptophan and contains "niacytin" (bound niacin), often leading to Pellagra in endemic areas.

Question 168: Folinic acid is:

A. 5-formyl tetrahydrofolate (Correct Answer)
B. 5-formyl dihydrofolate
C. N5, N10-methylene tetrahydrofolate
D. N5, N10-methylene dihydrofolate

Explanation: ### **Explanation** **1. Why Option A is Correct:** Folinic acid, also known as **Leucovorin** or Citrovorum factor, is the chemically stable derivative of folic acid. Structurally, it is **5-formyl tetrahydrofolate (5-formyl-THF)**. Unlike dietary folic acid, which requires the enzyme Dihydrofolate Reductase (DHFR) to be converted into its active form (THF), folinic acid is already a reduced form of folate. This allows it to bypass the DHFR-mediated step and directly enter the folate pool to support DNA synthesis. **2. Why the Other Options are Incorrect:** * **Option B & D:** Dihydrofolate (DHF) is the partially reduced form of folate. Folinic acid is a derivative of the fully reduced form, **Tetrahydrofolate (THF)**. Any option containing "dihydrofolate" is structurally incorrect for folinic acid. * **Option C:** N5, N10-methylene THF is a specific intermediate in the folate cycle used primarily by the enzyme thymidylate synthase. While it is a form of active folate, it is not the chemical name for Folinic acid/Leucovorin. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Leucovorin Rescue:** It is used to "rescue" normal cells from the toxicity of high-dose **Methotrexate** (a DHFR inhibitor). Since Methotrexate blocks the production of THF, providing 5-formyl-THF bypasses the block. * **5-Fluorouracil (5-FU) Potentiation:** In colorectal cancer treatment, Folinic acid is given with 5-FU. It stabilizes the binding of 5-FU to thymidylate synthase, enhancing the drug's cytotoxic effect. * **Methanol Toxicity:** It is used to enhance the metabolism of formate to CO₂ and water. * **Note:** Do not confuse Folinic acid with **Folic acid** (Vitamin B9) or **Folnic acid** (an older term for the same).

Question 169: Thiamine level is best monitored by?

A. Transketolase level in blood (Correct Answer)
B. Thiamine level in blood
C. G6PD activity
D. Reticulocytosis

Explanation: **Explanation:** **Thiamine (Vitamin B1)** is a crucial cofactor for several key enzymes in carbohydrate metabolism. The most reliable method to assess functional thiamine status is the measurement of **Erythrocyte Transketolase Activity (ETKA)**. **Why Option A is correct:** Transketolase is an enzyme in the Pentose Phosphate Pathway (HMP Shunt) that requires **Thiamine Pyrophosphate (TPP)** as a coenzyme. In thiamine deficiency, the activity of this enzyme in red blood cells decreases. The gold standard test involves measuring transketolase activity before and after adding TPP. An increase in activity (>15–25%) confirms a deficiency (the "TPP effect"). This is more accurate than measuring blood levels because it reflects the actual functional utilization of the vitamin within cells. **Why other options are incorrect:** * **B. Thiamine level in blood:** Serum thiamine levels are often unreliable as they do not accurately reflect total body stores or intracellular functional status. * **C. G6PD activity:** This enzyme is also part of the HMP shunt, but it is dependent on NADP+, not thiamine. It is used to screen for G6PD deficiency (hemolytic anemia). * **D. Reticulocytosis:** This refers to an increase in immature red blood cells, typically seen in response to blood loss or hemolysis, and has no direct diagnostic link to thiamine levels. **High-Yield Clinical Pearls for NEET-PG:** * **Key TPP-dependent enzymes:** Pyruvate Dehydrogenase (PDH), $\alpha$-Ketoglutarate Dehydrogenase, and Transketolase. * **Deficiency Syndromes:** * **Dry Beriberi:** Polyneuritis and muscle wasting. * **Wet Beriberi:** High-output heart failure and edema. * **Wernicke-Korsakoff Syndrome:** Classic triad of Ataxia, Ophthalmoplegia, and Confusion (common in chronic alcoholics). * **Biochemical marker:** Elevated blood **pyruvate and lactate** levels are often seen in thiamine deficiency due to the failure of the PDH complex.

Question 170: Folate trap occurs due to the deficiency of which vitamin?

A. Thiamine
B. Biotin
C. Folic acid
D. Vitamin B12 (Correct Answer)

Explanation: ### Explanation **The Correct Answer: Vitamin B12 (Cobalamin)** The "Folate Trap" hypothesis explains why Vitamin B12 deficiency leads to a functional folate deficiency. In the body, **N5-methyl tetrahydrofolate (N5-methyl THF)** is the major storage form of folate. To be reused for DNA synthesis, it must transfer its methyl group to homocysteine to form methionine. This reaction is catalyzed by the enzyme **Methionine Synthase**, which requires **Vitamin B12** as an essential cofactor. When Vitamin B12 is deficient: 1. The methyl group cannot be removed from N5-methyl THF. 2. Folate remains "trapped" in the N5-methyl form, which is metabolically inactive. 3. This leads to a shortage of other folate derivatives (like N5, N10-methylene THF) required for dTMP and DNA synthesis, resulting in **Megaloblastic Anemia**. --- ### Why the Other Options are Incorrect: * **A. Thiamine (B1):** Acts as a cofactor for oxidative decarboxylation (e.g., Pyruvate Dehydrogenase). Deficiency causes Beriberi or Wernicke-Korsakoff syndrome, not folate trapping. * **B. Biotin (B7):** Involved in carboxylation reactions (e.g., Pyruvate carboxylase). Deficiency leads to dermatitis and alopecia. * **C. Folic acid (B9):** While the trap involves folate, the *cause* of the trap is the absence of B12. Supplementing folate can bypass the trap and treat the anemia, but it will not fix the underlying B12 deficiency (risking neurological damage). --- ### High-Yield NEET-PG Pearls: * **The "Methyl-Folate Trap"** explains why B12 deficiency causes macrocytic anemia. * **Biochemical Marker:** In B12 deficiency, both **Homocysteine** and **Methylmalonic Acid (MMA)** levels are elevated. In pure folate deficiency, only Homocysteine is elevated. * **Clinical Warning:** Giving high doses of folate to a B12-deficient patient corrects the anemia but worsens the **Subacute Combined Degeneration (SCD)** of the spinal cord.

Practice by Chapter

Fat-Soluble Vitamins: A, D, E, K

Practice Questions

Vitamin A and Vision

Practice Questions

Vitamin D and Calcium Metabolism

Practice Questions

Vitamin E and Antioxidant Functions

Practice Questions

Vitamin K and Blood Coagulation

Practice Questions

Water-Soluble Vitamins: B Complex and C

Practice Questions

Thiamine (B1) and Pyruvate Dehydrogenase

Practice Questions

Riboflavin (B2) and Flavin Coenzymes

Practice Questions

Niacin and NAD/NADP

Practice Questions

Vitamin B6 and Transamination

Practice Questions

Folate and Vitamin B12 in One-Carbon Metabolism

Practice Questions

Vitamin C and Collagen Synthesis

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free